CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 4 filers reported holding CROSS CTRY HEALTHCARE INC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,583,269 | -60.7% | 114,398 | -46.8% | 0.00% | -100.0% |
Q1 2024 | $4,024,632 | -46.2% | 214,991 | -35.0% | 0.00% | 0.0% |
Q4 2023 | $7,484,806 | -7.9% | 330,601 | +0.9% | 0.00% | -50.0% |
Q3 2023 | $8,122,518 | -21.3% | 327,653 | -10.9% | 0.00% | 0.0% |
Q2 2023 | $10,324,202 | -39.3% | 367,671 | -51.7% | 0.00% | -50.0% |
Q1 2023 | $17,003,220 | +20.3% | 761,793 | +43.2% | 0.00% | +33.3% |
Q4 2022 | $14,134,921 | +400776.9% | 531,988 | +328.0% | 0.00% | +200.0% |
Q3 2022 | $3,526 | -42.4% | 124,292 | -57.7% | 0.00% | -50.0% |
Q2 2022 | $6,118 | -99.9% | 293,693 | +53.7% | 0.00% | +100.0% |
Q1 2022 | $4,141,000 | +13.8% | 191,110 | +45.8% | 0.00% | 0.0% |
Q4 2021 | $3,638,000 | +328.5% | 131,047 | +227.9% | 0.00% | – |
Q3 2021 | $849,000 | -60.0% | 39,962 | -68.9% | 0.00% | – |
Q2 2021 | $2,122,000 | +177.0% | 128,538 | +109.6% | 0.00% | – |
Q1 2021 | $766,000 | +14.2% | 61,325 | -19.0% | 0.00% | – |
Q4 2020 | $671,000 | -26.3% | 75,703 | -46.1% | 0.00% | – |
Q3 2020 | $911,000 | -38.6% | 140,389 | -41.7% | 0.00% | – |
Q2 2020 | $1,484,000 | -35.9% | 240,942 | -29.9% | 0.00% | -100.0% |
Q1 2020 | $2,316,000 | +6.5% | 343,710 | +83.7% | 0.00% | 0.0% |
Q4 2019 | $2,174,000 | +95.0% | 187,112 | +72.8% | 0.00% | – |
Q3 2019 | $1,115,000 | +45.6% | 108,274 | +32.6% | 0.00% | – |
Q2 2019 | $766,000 | -57.8% | 81,640 | -68.4% | 0.00% | -100.0% |
Q1 2019 | $1,817,000 | -18.6% | 258,496 | -15.1% | 0.00% | 0.0% |
Q4 2018 | $2,231,000 | -43.0% | 304,324 | -32.1% | 0.00% | 0.0% |
Q3 2018 | $3,914,000 | +7.9% | 448,267 | +39.0% | 0.00% | 0.0% |
Q2 2018 | $3,628,000 | +158.6% | 322,558 | +155.4% | 0.00% | – |
Q1 2018 | $1,403,000 | -24.8% | 126,278 | -13.6% | 0.00% | – |
Q4 2017 | $1,865,000 | -15.2% | 146,208 | -5.4% | 0.00% | -100.0% |
Q3 2017 | $2,200,000 | +179.2% | 154,557 | +153.2% | 0.00% | – |
Q2 2017 | $788,000 | -39.3% | 61,031 | -32.5% | 0.00% | – |
Q1 2017 | $1,299,000 | -30.5% | 90,427 | -24.5% | 0.00% | -100.0% |
Q4 2016 | $1,869,000 | +525.1% | 119,747 | +457.6% | 0.00% | – |
Q2 2016 | $299,000 | -25.2% | 21,477 | -37.6% | 0.00% | – |
Q1 2016 | $400,000 | +61.3% | 34,434 | +127.3% | 0.00% | – |
Q4 2015 | $248,000 | -28.3% | 15,152 | -40.4% | 0.00% | – |
Q3 2015 | $346,000 | -89.3% | 25,419 | -90.2% | 0.00% | -100.0% |
Q4 2014 | $3,223,000 | +10.1% | 258,210 | -18.1% | 0.00% | +100.0% |
Q3 2014 | $2,927,000 | +116.0% | 315,111 | +51.6% | 0.00% | – |
Q2 2014 | $1,355,000 | +486.6% | 207,870 | +625.8% | 0.00% | – |
Q1 2014 | $231,000 | -80.8% | 28,642 | -76.2% | 0.00% | – |
Q4 2013 | $1,201,000 | +138.8% | 120,365 | +44.5% | 0.00% | – |
Q3 2013 | $503,000 | +19.5% | 83,293 | +2.0% | 0.00% | – |
Q2 2013 | $421,000 | +5.0% | 81,640 | -2.3% | 0.00% | – |
Q4 2012 | $401,000 | -2.0% | 83,525 | -3.5% | 0.00% | – |
Q3 2012 | $409,000 | -5.1% | 86,545 | -12.2% | 0.00% | – |
Q2 2012 | $431,000 | +452.6% | 98,521 | +531.4% | 0.00% | – |
Q1 2012 | $78,000 | – | 15,604 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcoe Capital Management, LLC | 1,143,625 | $23,822,000 | 3.28% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,194,340 | $45,708,000 | 1.59% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 704,526 | $14,676,000 | 1.51% |
Mesirow Financial Investment Management, Inc. | 12,643 | $263,000 | 1.27% |
Aristotle Capital Boston, LLC | 1,638,612 | $34,132,000 | 1.02% |
Zebra Capital Management LLC | 14,351 | $299,000 | 0.88% |
Alpha DNA Investment Management LLC | 49,398 | $1,028,000 | 0.88% |
SummerHaven Investment Management, LLC | 55,577 | $1,158,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 145,700 | $3,035,000 | 0.74% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,900 | $2,018,000 | 0.51% |